Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
- One-time gene therapy VERVE-102 lowers bad cholesterol by up to 62 percent in trials
- VERVE-102 works by turning off the PCSK9 gene to reduce LDL cholesterol in the liver
- Trial involved 35 adults with familial hypercholesterolaemia or premature coronary artery disease
Read more
Advertisement